Century Therapeutics (IPSC) Return on Sales (2022 - 2025)

Century Therapeutics (IPSC) has 4 years of Return on Sales data on file, last reported at 0.0% in Q4 2025.

• Return on Sales for Q4 2025 came in at 0.0%, up 8.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (up 19.0% YoY), and the FY2025 annual result was 0.0%, up 19.0% from the prior year.
• Return on Sales grew to 0.0% in Q4 2025 per IPSC's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Sales peaked at 0.01% in Q1 2025 and troughed at 3.36% in Q2 2023.
• A 4-year average of 0.61% and a median of 0.28% in 2024 frame the typical range for Return on Sales.
• The sharpest annual moves came in 2023 and 2024: Return on Sales plunged 314 bps in 2023, then soared 296 bps in 2024.
• A 4-year view of Return on Sales shows it stood at 0.61% in 2022, then slumped by 142 bps to 1.47% in 2023, then soared by 94 bps to 0.08% in 2024, then soared by 100 bps to 0.0% in 2025.
• Business Quant data shows IPSC's Return on Sales at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.